SEARCH

SEARCH BY CITATION

References

  • 1
    Margreiter R, Brandacher G, Ninkovic M, Steurer W, Kreczy A, Schneeberger S. A double-hand transplant can be worth the effort! Transplantation 2002; 74: 8590.
  • 2
    Piza-Katzer H, Ninkovic M, Pechlaner S, Gabl M, Ninkovic M, Hussl H. Double hand transplantation: Functional outcome after 18 months. J Hand Surg [Br] 2002; 27: 385390.
  • 3
    Dubernard JM, Owen E, Herzberg G et al. Human hand allograft: Report on first 6 months. Lancet 1999; 353: 13151320.
  • 4
    Jones JW, Gruber SA, Barker JH, Breidenbach WC. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. N Engl J Med 2000; 343: 468473.
  • 5
    Dubernard JM, Petruzzo P, Lanzetta M et al. Functional results of the first human double-hand transplantation. Ann Surg 2003; 238: 128136.
  • 6
    Lanzetta M, Petruzzo P, Margreiter R et al. The international registry on hand and composite tissue transplantation. Transplantation 2005; 79: 12101214.
  • 7
    Costanzo MR, Naftel DC, Pritzker MR et al. Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors. Cardiac transplant research database. J Heart Lung Transplant 1998; 17: 744753.
  • 8
    Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 23262333.
  • 9
    Sharples LD, Jackson CH, Parameshwar J, Wallwork J, Large SR. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation 2003; 76: 679682.
  • 10
    Schneeberger S, Kreczy A, Brandacher G, Steurer W, Margreiter R. Steroid- and ATG-resistant rejection after double forearm transplantation responds to campath-1H. Am J Transplant 2004; 4: 13721374.
  • 11
    Brenneis C, Löscher WN, Egger KE et al. Cortical motor activation patterns following hand transplantation and replantation. J Hand Surg 2005; 30b: 530533.
  • 12
    Eisen HJ, Tuzcu EM, Dorent R et al. RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349: 847858.
  • 13
    Ruiz JC, Campistol JM, Grinyo JM et al. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions. Transplantation 2004; 78: 13121318.
  • 14
    Guba M, Von Breitenbuch P, Steinbauer M et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor. Nat Med 2002; 8: 128135.
  • 15
    Majumder PK, Febbo PG, Bikoff R et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004; 10: 594601.
  • 16
    Stallone G, Schena A, Infante B et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 13171323.
  • 17
    Perfetti C. Der hemiplegische Patient (Kognitiv therapeutische Übungen). Pflaum Verlag Munich , 1997.